Completed OBSERVATIONAL NCT01706497

Predictive Value of the FORE-SIGHT™ Monitor for Hemodynamic Deterioration

Validation of the Predictive Value of the FORE-SIGHT™ Monitor for Early Detection of Hemodynamic Deterioration After Pediatric Cardiac Surgery. A Data-mining Study.

Sponsor: CAS Medical Systems, Inc.

Conditions Pediatric Congenital Heart Surgery

Interventions Cerebral tissue oxygen saturation monitoring, blinded

Updated 10 times since 2017 Last updated: May 14, 2019 Started: Oct 31, 2012 Primary completion: Jan 31, 2016 Completion: Jan 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Pediatric Congenital Heart Surgery, this trial is completed. The trial is conducted by CAS Medical Systems, Inc. and has accumulated 10 data snapshots since 2012. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2023 — Jul 2024 [monthly]

Completed
Dec 2022 — Jan 2023 [monthly]

Completed
Jan 2021 — Dec 2022 [monthly]

Completed

▶ Show 5 earlier versions

Jun 2019 — Jan 2021 [monthly]

Completed
Aug 2018 — Jun 2019 [monthly]

Completed
Jun 2018 — Aug 2018 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Oct 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

CAS Medical Systems, Inc.
KU Leuven

Data source: KU Leuven

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Leuven, Belgium